Max Farina, MD, is a Principal at 5AM Ventures, where experience includes progressively advancing from Associate to Senior Associate since February 2021. Additionally, Max serves as a Board Observer for multiple companies, including Karius, Portal Instruments, Skye Bioscience Inc., Fellow, TMRW Life Sciences, Precede Biosciences, Kinaset Therapeutics, and Scientist.com. Prior involvement includes serving as a Board Observer for Entrada Therapeutics until November 2021. Max holds a Doctor of Medicine from Yale School of Medicine (2019) and a Master of Business Administration from Yale School of Management (2019), following a Bachelor of Science degree in Neuroscience and Behavioral Biology and Music Performance from Emory University (2014).
This person is not in the org chart
This person is not in any teams
This person is not in any offices